Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008

DANBURY, Conn., March 20 Biodel Inc.(Nasdaq: BIOD) today announced that Gerard Michel, Chief Financial Officer,Vice President of Corporate Development and Treasurer of Biodel, will presenta corporate update at the BioCentury Future Leaders Conference on Thursday,March 27, 2008 at 3:00 p.m. Eastern Time. The conference will be held at theMillennium Broadway Hotel and Conference Center in New York City.

Interested parties may access a link to a live webcast of the corporatepresentation in the investor relations section of Biodel's website atwww.biodel.com. An archive of the presentation will be available at the samelocation.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on thedevelopment and commercialization of innovative treatments for endocrinedisorders, such as diabetes and osteoporosis. Biodel's product candidates aredeveloped by using VIAdel(TM) technology, which reformulates existing FDA-approved peptide drugs. The Company's lead product candidate, VIAject(TM), isan ultra rapid-acting injectable meal-time insulin in development for use bypatients with Type 1 or Type 2 diabetes. VIAject(TM) is currently being testedin two pivotal Phase III clinical trials. Biodel's pipeline also includesVIAtab(TM), a sublingual tablet formulation of insulin in the Phase I stage ofclinical testing, and two pre-clinical osteoporosis product candidates. Forfurther information regarding Biodel, please visit the Company's website atwww.biodel.com.BIOD-G

SOURCE Biodel Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...